Extended Valganciclovir Prophylaxis Is Well Tolerated in Pediatric Kidney Transplant Recipients

被引:0
|
作者
Benchimol, C. [1 ]
Tedesco Silva, H., Jr. [2 ]
Varela-Fascinetto, G. [3 ]
Genevray, M. [4 ]
Bradley, D. [5 ]
Ives, J. [5 ]
机构
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Univ Fed Sao Paulo, Sao Paulo, Brazil
[3] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico
[4] F Hoffmann La Roche, Basel, Switzerland
[5] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A342
引用
收藏
页码:497 / 497
页数:1
相关论文
共 50 条
  • [1] Extended Valganciclovir Prophylaxis Is Well Tolerated in Pediatric Kidney Transplant Recipients.
    Benchimol, C.
    Tedesco Silva, H., Jr.
    Varela-Fascinetto, G.
    Genevray, M.
    Bradley, D.
    Ives, J.
    TRANSPLANTATION, 2014, 98 : 497 - 497
  • [2] Oral valganciclovir prophylaxis in kidney transplant recipients
    Manuel, O.
    Fellay, J.
    Venetz, J-P.
    Sturzenegger, N.
    Meylan, R.
    Pascual, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S16 - S16
  • [3] Valganciclovir as CMV prophylaxis in pediatric transplant recipients.
    Bonatti, H
    Wiesmayr, S
    Junngraithmayr, TC
    Margreiter, R
    Zimmerhackl, LB
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 98 - 98
  • [4] SHORT VERSUS EXTENDED TERM VALGANCICLOVIR PROPHYLAXIS FOR CYTOMEGALOVIRUS INFECTION IN PEDIATRIC KIDNEY TRANSPLANT
    Hashim, Faris
    Dharnidharka, Vikas
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (04) : A45 - A45
  • [5] Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients
    Clark, BS
    Chang, IF
    Karpen, SJ
    Herrera, L
    Scott, JD
    Bristow, LJ
    Quirós-Tejeira, RE
    Goss, JA
    TRANSPLANTATION, 2004, 77 (09) : 1480 - 1480
  • [6] Valacyclovir or valganciclovir for cytomegalovirus prophylaxis: A randomized controlled trial in adult and pediatric kidney transplant recipients
    Verghese, Priya S.
    Evans, Michael D.
    Hanson, Amy
    Hathi, Justina
    Chinnakotla, Srinath
    Matas, Arthur
    Balfour Jr, Henry H.
    JOURNAL OF CLINICAL VIROLOGY, 2024, 172
  • [7] Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience
    Iida, Takaya
    Miura, Kenichiro
    Ban, Hideki
    Ando, Taro
    Shirai, Yoko
    Ishiwa, Sho
    Shiratori, Atsutoshi
    Kaneko, Naoto
    Yabuuchi, Tomoo
    Ishizuka, Kiyonobu
    Takaiwa, Masanori
    Suyama, Kazuhide
    Hisano, Masataka
    Hattori, Motoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (05) : 531 - 536
  • [8] Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience
    Takaya Iida
    Kenichiro Miura
    Hideki Ban
    Taro Ando
    Yoko Shirai
    Sho Ishiwa
    Atsutoshi Shiratori
    Naoto Kaneko
    Tomoo Yabuuchi
    Kiyonobu Ishizuka
    Masanori Takaiwa
    Kazuhide Suyama
    Masataka Hisano
    Motoshi Hattori
    Clinical and Experimental Nephrology, 2021, 25 : 531 - 536
  • [9] Multicenter Analysis of Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients
    Foca, Marc
    Demirhan, Salih
    Munoz, Flor M.
    Deray, Kristen G. Valencia
    Bocchini, Claire E.
    Sharma, Tanvi S.
    Sherman, Gilad
    Muller, William J.
    Heald-Sargent, Taylor
    Danziger-Isakov, Lara
    Blum, Samantha
    Boguniewicz, Juri
    Bacon, Samantha
    Joseph, Tuhina
    Smith, Jodi
    Ardura, Monica, I
    Su, Yin
    Maron, Gabriela M.
    Ferrolino, Jose
    Herold, Betsy C.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (07):
  • [10] Increased Incidence of Leucopenia With FDA Approved Valganciclovir Dosing for CMV Prophylaxis in Pediatric Kidney Transplant Recipients
    Bhatnagar, S.
    Palma, K.
    Palmer, J.
    Baluarte, J.
    Amaral, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 501 - 501